AbboMax, Inc Offers a Portfolio of 70 Anti-CD Antibodies

    SAN JOSE, CA, April 07, 2019 /24-7PressRelease/ -- AbboMax, Inc offers a portfolio of over 70 anti-CD antibodies. Some of these antibodies have proven to be essential for biomedical research, as well as in biotechnology. The human cluster of differentiation (CD) antigens are expressed on cells of the human immune system (leukocytes) and on other cell types. Cluster of differentiation molecules are defined or classified by the reference monoclonal antibodies to which they bind. Each unique molecule is assigned a different number designation, which allows identification of cell phenotypes. The CD nomenclature was proposed and established in the 1st International Workshop and Conference on Human Leukocyte Differentiation Antigens (HLDA). This system was intended for the classification of the many monoclonal antibodies generated by different laboratories around the globe against epitopes on the surface molecules of leukocytes. CD antigens now include some intracellular molecules. CD molecules can act in numerous ways, often acting as receptors or ligands. The CD antigens interactions are fundamental to cell signaling. Some CD proteins have other functions, such as cell adhesion. Many cells express more than one CD marker. The CD antigens are commonly used as cell markers in immunophenotyping, allowing cells to be defined based on what molecules are present on their surface. Some CD antibodies have been recognized as invaluable tools for the treatment of several malignancies and autoimmune diseases. Now over 370 CDs for humans are identified.

AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. We specialize in high-quality custom service and products focusing on antibody development, including rabbit polyclonal, phosphospecific antibodies, IHC grade monoclonal antibodies, FFPE cell pellets slides, tissue/cell blocks and CRO services
CD markers /Cell Types

CD45 Leukocyte common antigen-All hematopoietic cells except erythrocytes and platelets
CD19, CD20, CD22CD45-B lymphocytes
CD3, CD5, CD7, CD45-T lymphocytes
CD11b, CD15, CD45, CD144-Granulocytes
CD4, CD11b, CD14, D15, CD16, CD45-Monocytes
CD45,CD61-Trombocytes
CD!, CD4, CD11c, CD14, CD45,CD141,CD303-Dentritic Cells
CD41, CD61-Platelets
CD235a- Erythrocytes
CD4,CD11b, CD14, CD16 CD68, CD91, CD45-Macrophages

CD antibodies available at AbboMax
Polyclonal anti-CD antibodies: CD1a, CD2, CD3, CD4, CD5, CD7, CD8, CD9, CD10, CD11b, CD14, CD16, CD17, CD19, CD20, CD23, CD25, CD29, CD30, CD31, CD34, CD38, CD40, CD 44, CD45, CD54, CD72, CD79a, CD95, CD99, CD105, CD117, CD133, CD133 (biotinylated), CD136, CD 136 (phosphorylated), CD138, CD146, CD147, CD154, CD156b, CD253

Monoclonal anti-CD antibodies: CD1a, CD2, CD3, CD4, CD5, CD7, CD8, CD9, CD11b, CD14, CD15, CD19, CD20, CD21, CD22, CD25, CD28, CD30, CD33, CD34, CD38, CD40, CD44, CD45, CD45RO, CD45RA, CD56, CD58, CD103, CD113 c-kit, CD117, CD133, CD134, TCR, HLA-DR

Contact Information: AbboMax, Inc. Natasha Raysberg, Ph.D. www.abbomax.com, [email protected]

AbboMax has been involved in researching, developing and manufacturing of high performance antibodies and related immunoassay reagents for many years. We specialize in antibody and assay development, provide high-quality custom service. AbboMax is focusing on phosphospecific antibodies, IHC grade monoclonal antibodies, FFPE cell pellets slides, tissue/cell blocks and CRO services including recombinant protein, custom bio-conjugation, antibody fragmentation, Antibody Epitope Mapping (AEM), scale-up process for pharmaceutical companies and CLIA lab. All the manufacturing activities are performed in our the Silicon Valley Core Facility located in San Jose, California. We can provide bulk quantities at economical prices, and guarantee a fast delivery with high quality products.

# # #